Hormonal
Preclinical evidence suggests GLP-1 receptor agonists may offer cardioprotective benefits beyond weight loss, such as reducing fibrosis and inflammation, but this remains unproven in humans.
Current human trials show GLP-1 benefits are mostly due to weight loss. However, animal studies suggest the drug might also directly reduce heart inflammation and fibrosis. This potential direct benefit is not yet proven in humans, so patients should focus on the proven weight loss benefits while researchers investigate these additional mechanisms.
Apart from improving glycaemic control and exercise capacity, semaglutide-treated mice showed an overall improvement in cardiac performance by reduction in natriuretic peptide levels, inflammatory responses, fibrosis as well as attenuated left ventricular hypertrophy... To date, only one study compared the effects of GLP-1RA with caloric restriction in cardiometabolic HFpEF [55&&].
Why this rating
Based on preclinical mouse models, not human clinical trials.
Source
Beyond Weight Loss: the Emerging Role of Incretin-Based Treatments in Cardiometabolic HFpEF
Federico Capone et al. · Current Opinion in Cardiology · 2024
DOI 10.1097/hco.0000000000001117
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →